找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

(版块PHARMACOLOGY & PHARMACY(药理学与药学)版块期刊总数:274)
新窗
投票 SCIE期刊PHARMACOGENOMICS 2024/2025影响因子:1.967 (PHARMACOGENOMICS) (1462-2416). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Cit  ...234
Total Citations:3248; 2023 JIF:1.967; JIFRank: 231/354 ; Rank-JIF: 231; Number-of-JIF:354; 5 Year JIF:1.924; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.7; Immediacy Index:0.6; Immediacy Index-dealt:0.661; 2023 JCI:0.44; JCI Rank: 257/354 ; Total Articles:60; JCI Quartile:Q3; JCI Percentile:27.54; Eigenfactor:0.002; Normalized Eigenfactor:0.409; Article Influence Score:0.46; JIF Percentile:34.9; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:75; % of Articles in Citable items:0.8; Cited Half-Life:8.9; Citing Half-Life:6.6; % of OA Gold:0.1116; Publisher name:SPRINGER; Publisher address:ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, United S
投票 SCIE期刊CLINICAL PHARMACOKINETICS 2024/2025影响因子:4.693 (CLIN PHARMACOKINET) (0312-5963). (PHARMACOLOGY & PHARMACY)(药理学与药学)  ...234
Total Citations:10794; 2023 JIF:4.693; JIFRank: 57/354 ; Rank-JIF: 57; Number-of-JIF:354; 5 Year JIF:5.287; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.4; Immediacy Index:0.7; Immediacy Index-dealt:0.763; 2023 JCI:1.09; JCI Rank: 70/354 ; Total Articles:89; JCI Quartile:Q1; JCI Percentile:80.37; Eigenfactor:0.007; Normalized Eigenfactor:1.431; Article Influence Score:1.415; JIF Percentile:84; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:121; % of Articles in Citable items:0.7355; Cited Half-Life:11.9; Citing Half-Life:7.6; % of OA Gold:0.5786; Publisher name:ELSEVIER SCIENCE INC; Publisher address:STE 800, 230 PARK AVE, NEW YORK, USA,
投票 SCIE期刊Pharmacological Reports 2024/2025影响因子:3.631 (PHARMACOL REP) (1734-1140). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science  ...234
Total Citations:5868; 2023 JIF:3.631; JIFRank: 94/354 ; Rank-JIF: 94; Number-of-JIF:354; 5 Year JIF:3.238; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.6; Immediacy Index:0.9; Immediacy Index-dealt:0.985; 2023 JCI:0.91; JCI Rank: 98/354 ; Total Articles:76; JCI Quartile:Q2; JCI Percentile:72.46; Eigenfactor:0.004; Normalized Eigenfactor:0.779; Article Influence Score:0.581; JIF Percentile:73.6; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:114; % of Articles in Citable items:0.6667; Cited Half-Life:7; Citing Half-Life:7.5; % of OA Gold:0.4282; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MI
投票 SCIE期刊Neurotherapeutics 2024/2025影响因子:5.618 (NEUROTHERAPEUTICS) (1933-7213). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science C  ...234
Total Citations:8591; 2023 JIF:5.618; JIFRank: 31/354 ; Rank-JIF: 31; Number-of-JIF:354; 5 Year JIF:6.993; 5 Year JIF Quartile:Q1; JIF Without Self Cites:5.5; Immediacy Index:1.3; Immediacy Index-dealt:1.313; 2023 JCI:1.39; JCI Rank: 35/354 ; Total Articles:65; JCI Quartile:Q1; JCI Percentile:86.29; Eigenfactor:0.01; Normalized Eigenfactor:2.204; Article Influence Score:1.843; JIF Percentile:86.9; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:108; % of Articles in Citable items:0.6019; Cited Half-Life:5.6; Citing Half-Life:7.7; % of OA Gold:0.9833; Publisher name:BRILL; Publisher address:PLANTIJNSTRAAT 2, P O BOX 9000, LEIDEN, NETHERLANDS,
投票 SCIE期刊BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 2024/2025影响因子:2.701 (BASIC CLIN PHARMACOL) (1742-7835). (PHARMACOLOGY  ...234
Total Citations:5523; 2023 JIF:2.701; JIFRank: 167/354 ; Rank-JIF: 167; Number-of-JIF:354; 5 Year JIF:3.222; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.6; Immediacy Index:1.2; Immediacy Index-dealt:1.268; 2023 JCI:0.61; JCI Rank: 199/354 ; Total Articles:101; JCI Quartile:Q3; JCI Percentile:37.26; Eigenfactor:0.004; Normalized Eigenfactor:0.851; Article Influence Score:0.697; JIF Percentile:47.6; JIF Quartile:Q3; AIS Quartile:Q2; Citable Items:120; % of Articles in Citable items:0.8417; Cited Half-Life:7.4; Citing Half-Life:6.8; % of OA Gold:0.3921; Publisher name:INST BIOLOSKA ISTRAZIVANJA SINISA STANKOVIC; Publisher address:29 NOVEMBR
投票 SCIE期刊Endocrine Metabolic & Immune Disorders-Drug Targets 2024/2025影响因子:2.108 (ENDOCR METAB IMMUNE) (1871-5303). (PHARM  ...234
Total Citations:2408; 2023 JIF:2.108; JIFRank: 222/354 ; Rank-JIF: 222; Number-of-JIF:354; 5 Year JIF:2.294; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.9; Immediacy Index:0.9; Immediacy Index-dealt:0.919; 2023 JCI:0.42; JCI Rank: 265/354 ; Total Articles:116; JCI Quartile:Q4; JCI Percentile:23.48; Eigenfactor:0.002; Normalized Eigenfactor:0.5; Article Influence Score:0.372; JIF Percentile:20.7; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:176; % of Articles in Citable items:0.6591; Cited Half-Life:3.8; Citing Half-Life:7.6; % of OA Gold:0.0165; Publisher name:TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MILTON PARK, ABING
投票 SCIE期刊Expert Review of Anti-Infective Therapy 2024/2025影响因子:4.287 (EXPERT REV ANTI-INFE) (1478-7210). (PHARMACOLOGY & P  ...234
Total Citations:6152; 2023 JIF:4.287; JIFRank: 75/354 ; Rank-JIF: 75; Number-of-JIF:354; 5 Year JIF:5.734; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.1; Immediacy Index:1.3; Immediacy Index-dealt:1.398; 2023 JCI:0.74; JCI Rank: 149/354 ; Total Articles:42; JCI Quartile:Q2; JCI Percentile:58.07; Eigenfactor:0.006; Normalized Eigenfactor:1.214; Article Influence Score:1.34; JIF Percentile:71.1; JIF Quartile:Q2; AIS Quartile:Q1; Citable Items:98; % of Articles in Citable items:0.4286; Cited Half-Life:6.3; Citing Half-Life:5.2; % of OA Gold:0.1024; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, M
投票 SCIE期刊Current Vascular Pharmacology 2024/2025影响因子:2.877 (CURR VASC PHARMACOL) (1570-1611). (PHARMACOLOGY & PHARMACY)(药理  ...234
Total Citations:2275; 2023 JIF:2.877; JIFRank: 158/354 ; Rank-JIF: 158; Number-of-JIF:354; 5 Year JIF:3.523; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.7; Immediacy Index:0.9; Immediacy Index-dealt:0.966; 2023 JCI:0.66; JCI Rank: 175/354 ; Total Articles:16; JCI Quartile:Q2; JCI Percentile:50.71; Eigenfactor:0.002; Normalized Eigenfactor:0.372; Article Influence Score:0.707; JIF Percentile:55.5; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:36; % of Articles in Citable items:0.4444; Cited Half-Life:6.5; Citing Half-Life:5.8; % of OA Gold:0.0299; Publisher name:SAMI PUBLISHING CO-SPC; Publisher address:DANESHJOU BOLV, PO BOX 6931936173
投票 SCIE期刊ARCHIV DER PHARMAZIE 2024/2025影响因子:4.355 (ARCH PHARM) (0365-6233). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citat  ...234
Total Citations:4935; 2023 JIF:4.355; JIFRank: 69/354 ; Rank-JIF: 69; Number-of-JIF:354; 5 Year JIF:4.475; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.1; Immediacy Index:0.8; Immediacy Index-dealt:0.845; 2023 JCI:0.99; JCI Rank: 83/354 ; Total Articles:134; JCI Quartile:Q1; JCI Percentile:76.84; Eigenfactor:0.003; Normalized Eigenfactor:0.608; Article Influence Score:0.559; JIF Percentile:69.3; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:160; % of Articles in Citable items:0.8375; Cited Half-Life:4.9; Citing Half-Life:6.7; % of OA Gold:0.17; Publisher name:KOREAN DERMATOLOGICAL ASSOC; Publisher address:305 SEOCHO NASAN, SUITE OFFICE
投票 SCIE期刊CHIRALITY 2024/2025影响因子:2.877 (CHIRALITY) (0899-0042). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citation Index Ex  ...234
Total Citations:3432; 2023 JIF:2.877; JIFRank: 158/354 ; Rank-JIF: 158; Number-of-JIF:354; 5 Year JIF:2.247; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.6; Immediacy Index:1; Immediacy Index-dealt:1.119; 2023 JCI:0.61; JCI Rank: 199/354 ; Total Articles:81; JCI Quartile:Q2; JCI Percentile:39.58; Eigenfactor:0.002; Normalized Eigenfactor:0.38; Article Influence Score:0.4; JIF Percentile:42.4; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:90; % of Articles in Citable items:0.9; Cited Half-Life:9.6; Citing Half-Life:9; % of OA Gold:0.1538; Publisher name:LIPPINCOTT WILLIAMS & WILKINS; Publisher address:TWO COMMERCE SQ, 2001 MARKET ST, PHI
投票 SCIE期刊CANCER CHEMOTHERAPY AND PHARMACOLOGY 2024/2025影响因子:2.771 (CANCER CHEMOTH PHARM) (0344-5704). (PHARMACOLOGY & PHAR  ...234
Total Citations:9563; 2023 JIF:2.771; JIFRank: 167/354 ; Rank-JIF: 167; Number-of-JIF:354; 5 Year JIF:2.703; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.6; Immediacy Index:0.5; Immediacy Index-dealt:0.534; 2023 JCI:0.7; JCI Rank: 163/354 ; Total Articles:109; JCI Quartile:Q2; JCI Percentile:54.1; Eigenfactor:0.006; Normalized Eigenfactor:1.231; Article Influence Score:0.703; JIF Percentile:53; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:120; % of Articles in Citable items:0.9083; Cited Half-Life:9.4; Citing Half-Life:6.9; % of OA Gold:0.2897; Publisher name:SCHLUETERSCHE VERLAGSGESELLSCHAFT MBH & CO KG; Publisher address:HANS-BOCKLER
投票 SCIE期刊JOURNAL OF FOOD AND DRUG ANALYSIS 2024/2025影响因子:2.675 (J FOOD DRUG ANAL) (1021-9498). (PHARMACOLOGY & PHARMACY)(药  ...234
Total Citations:5106; 2023 JIF:2.675; JIFRank: 173/354 ; Rank-JIF: 173; Number-of-JIF:354; 5 Year JIF:4.935; 5 Year JIF Quartile:Q1; JIF Without Self Cites:2.5; Immediacy Index:0.7; Immediacy Index-dealt:0.787; 2023 JCI:0.62; JCI Rank: 192/354 ; Total Articles:45; JCI Quartile:Q3; JCI Percentile:45.9; Eigenfactor:0.002; Normalized Eigenfactor:0.526; Article Influence Score:0.75; JIF Percentile:51.3; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:49; % of Articles in Citable items:0.9184; Cited Half-Life:6.9; Citing Half-Life:6.5; % of OA Gold:0.9452; Publisher name:IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC; Publisher address:445 HOES LA
投票 SCIE期刊ALIMENTARY PHARMACOLOGY & THERAPEUTICS 2024/2025影响因子:6.676 (ALIMENT PHARM THER) (0269-2813). (PHARMACOLOGY & PHAR  ...234
Total Citations:23934; 2023 JIF:6.676; JIFRank: 20/354 ; Rank-JIF: 20; Number-of-JIF:354; 5 Year JIF:7.432; 5 Year JIF Quartile:Q1; JIF Without Self Cites:6; Immediacy Index:2.8; Immediacy Index-dealt:2.887; 2023 JCI:1.75; JCI Rank: 18/354 ; Total Articles:146; JCI Quartile:Q1; JCI Percentile:95.06; Eigenfactor:0.025; Normalized Eigenfactor:5.544; Article Influence Score:2.713; JIF Percentile:94.5; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:172; % of Articles in Citable items:0.8488; Cited Half-Life:8.2; Citing Half-Life:5.3; % of OA Gold:0.2893; Publisher name:SPRINGER BASEL AG; Publisher address:PICASSOPLATZ 4, BASEL, SWITZERLAND, 4052
投票 SCIE期刊PHARMACOPSYCHIATRY 2024/2025影响因子:3.671 (PHARMACOPSYCHIATRY) (0176-3679). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science  ...234
Total Citations:1812; 2023 JIF:3.671; JIFRank: 94/354 ; Rank-JIF: 94; Number-of-JIF:354; 5 Year JIF:4.190; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.5; Immediacy Index:0.3; Immediacy Index-dealt:0.383; 2023 JCI:0.74; JCI Rank: 149/354 ; Total Articles:19; JCI Quartile:Q2; JCI Percentile:54.89; Eigenfactor:0.001; Normalized Eigenfactor:0.306; Article Influence Score:1.199; JIF Percentile:76.3; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:25; % of Articles in Citable items:0.76; Cited Half-Life:11.9; Citing Half-Life:9.6; % of OA Gold:0.2; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MILT
投票 SCIE期刊THERAPIE 2024/2025影响因子:2.296 (THERAPIE) (0040-5957). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citation Index Expa  ...234
Total Citations:1208; 2023 JIF:2.296; JIFRank: 204/354 ; Rank-JIF: 204; Number-of-JIF:354; 5 Year JIF:2.346; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.6; Immediacy Index:0.8; Immediacy Index-dealt:0.827; 2023 JCI:0.59; JCI Rank: 203/354 ; Total Articles:65; JCI Quartile:Q3; JCI Percentile:42.8; Eigenfactor:0.001; Normalized Eigenfactor:0.284; Article Influence Score:0.523; JIF Percentile:42.5; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:73; % of Articles in Citable items:0.8904; Cited Half-Life:4.5; Citing Half-Life:6.3; % of OA Gold:0.445; Publisher name:CASA EDITRICE LEO S OLSCHKI; Publisher address:VIUZZO DEL POZZETTO, 8, FLOREN
投票 SCIE期刊Journal of Pharmaceutical Investigation 2024/2025影响因子:5.377 (J PHARM INVEST) (2093-5552). (PHARMACOLOGY & PHARMAC  ...234
Total Citations:1721; 2023 JIF:5.377; JIFRank: 34/354 ; Rank-JIF: 34; Number-of-JIF:354; 5 Year JIF:NULL; 5 Year JIF Quartile:NULL; JIF Without Self Cites:4.9; Immediacy Index:0.5; Immediacy Index-dealt:0.545; 2023 JCI:1.1; JCI Rank: 68/354 ; Total Articles:25; JCI Quartile:Q1; JCI Percentile:80.93; Eigenfactor:0.001; Normalized Eigenfactor:0.283; Article Influence Score:0.419; JIF Percentile:90.5; JIF Quartile:Q1; AIS Quartile:NULL; Citable Items:42; % of Articles in Citable items:0.5952; Cited Half-Life:4.2; Citing Half-Life:7.2; % of OA Gold:0.0467; Publisher name:SAGE PUBLICATIONS LTD; Publisher address:1 OLIVERS YARD, 55 CITY ROAD, LONDO
投票 SCIE期刊INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY 2024/2025影响因子:2.115 (INT CLIN PSYCHOPHARM) (0268-1315). (PHARMACOLOGY &  ...234
Total Citations:1905; 2023 JIF:2.115; JIFRank: 210/354 ; Rank-JIF: 210; Number-of-JIF:354; 5 Year JIF:1.854; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.5; Immediacy Index:1.7; Immediacy Index-dealt:1.712; 2023 JCI:0.64; JCI Rank: 183/354 ; Total Articles:39; JCI Quartile:Q3; JCI Percentile:44.38; Eigenfactor:0.001; Normalized Eigenfactor:0.192; Article Influence Score:0.481; JIF Percentile:46.6; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:49; % of Articles in Citable items:0.7959; Cited Half-Life:12.8; Citing Half-Life:7.6; % of OA Gold:0.1825; Publisher name:KARE PUBL; Publisher address:Goztepe Mah. Fahrettin Kerim Gokay Caddesi. N
投票 SCIE期刊EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS 2024/2025影响因子:1.912 (EUR J DRUG METAB PH) (0378-7966). (  ...234
Total Citations:1636; 2023 JIF:1.912; JIFRank: 231/354 ; Rank-JIF: 231; Number-of-JIF:354; 5 Year JIF:2.259; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.8; Immediacy Index:0.4; Immediacy Index-dealt:0.423; 2023 JCI:0.52; JCI Rank: 227/354 ; Total Articles:51; JCI Quartile:Q3; JCI Percentile:36.02; Eigenfactor:0.001; Normalized Eigenfactor:0.317; Article Influence Score:0.494; JIF Percentile:34.9; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:57; % of Articles in Citable items:0.8947; Cited Half-Life:6.1; Citing Half-Life:7.7; % of OA Gold:0.2737; Publisher name:BRILL; Publisher address:PLANTIJNSTRAAT 2, P O BOX 9000, LEIDEN, NETHERLAND
投票 SCIE期刊MOLECULAR PHARMACEUTICS 2024/2025影响因子:4.515 (MOL PHARMACEUT) (1543-8384). (PHARMACOLOGY & PHARMACY)(药理学与药学)Scienc  ...234
Total Citations:22661; 2023 JIF:4.515; JIFRank: 60/354 ; Rank-JIF: 60; Number-of-JIF:354; 5 Year JIF:4.677; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.2; Immediacy Index:1; Immediacy Index-dealt:1.125; 2023 JCI:1.22; JCI Rank: 56/354 ; Total Articles:414; JCI Quartile:Q1; JCI Percentile:84.32; Eigenfactor:0.015; Normalized Eigenfactor:3.284; Article Influence Score:0.817; JIF Percentile:83.2; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:460; % of Articles in Citable items:0.9; Cited Half-Life:6.4; Citing Half-Life:7; % of OA Gold:0.1279; Publisher name:KOREAN AUDIOLOGICAL SOC; Publisher address:DEPT OTORHINOLARY-HEAD&NECK SURG, SEOUL
投票 SCIE期刊Molecular Diagnosis & Therapy 2024/2025影响因子:4.126 (MOL DIAGN THER) (1177-1062). (PHARMACOLOGY & PHARMACY)(药理学与药学)  ...234
Total Citations:1919; 2023 JIF:4.126; JIFRank: 78/354 ; Rank-JIF: 78; Number-of-JIF:354; 5 Year JIF:3.845; 5 Year JIF Quartile:Q2; JIF Without Self Cites:4; Immediacy Index:0.9; Immediacy Index-dealt:0.909; 2023 JCI:0.91; JCI Rank: 98/354 ; Total Articles:35; JCI Quartile:Q2; JCI Percentile:72.46; Eigenfactor:0.003; Normalized Eigenfactor:0.582; Article Influence Score:1.075; JIF Percentile:78.1; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:54; % of Articles in Citable items:0.6481; Cited Half-Life:4.9; Citing Half-Life:5.9; % of OA Gold:0.3353; Publisher name:SPRINGER/PLENUM PUBLISHERS; Publisher address:233 SPRING ST, NEW YORK, USA, NY,
下一页 »
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-7-31 00:53
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
返回顶部 返回版块